Sort
40,608 grants matching “prostate cancer”
Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer
$548,878Hyung L Kim · Cedars-Sinai Medical Center · R01 · FY2018 · CA
Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PET
$548,810Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA
Housing assistance, Outcomes, Medicare, and SEER (HOMES): using a novel data linkage to understand cancer inequities
$548,740Craig Evan Pollack · Johns Hopkins University · R01 · FY2025 · CA
Prostate Cancer Risk Enhancers
$548,636Peggy J Farnham · University Of Southern California · R01 · FY2018 · CA
DEFINING AND MODULATING BRCANESS TO IMPROVE THE PRECISION OF PROSTATE CANCER THERAPY
$548,486University Of Washington · · FY2021 · Defense Health Agency
Targeted Therapy to Receptors for LH-RH in Prostate Cancer
$548,459Jacek Pinski · University Of Southern California · R01 · FY2010 · CA
Admixture Mapping of Glaucoma Genes in African Americans
$548,440Michael A Hauser · Duke University · R01 · FY2010 · EY
Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction
$548,342Amy E Moran · Oregon Health & Science University · R37 · FY2021 · CA
Testing ATAD2 as a new therapeutic target for advanced prostate cancer
$548,333Tanya I Stoyanova · University Of California Los Angeles · R01 · FY2025 · CA
Case Control Study of Pancreas Cancer in Shanghai, China
$548,262Harvey A Risch · Yale University · R01 · FY2007 · CA
Next-Generation Whole-Body MRI for Detection and Assessment of Therapy Response in Bone Lesions
$548,249Ananth J Madhuranthakam · Ut Southwestern Medical Center · R01 · FY2023 · CA
ProstaFluor FDA Trial for Real-Time Margin Detection During Prostatectomy
$548,085David A. Benaron · Spectros Corporation · R01 · FY2014 · CA
Natural History of Prostatism: The Olmsted County Study
$548,077Jennifer Lynn St Sauver · Mayo Clinic Rochester · R01 · FY2008 · DK
Plk1 as a prognostic biomarker for prostate cancer
$548,025Xiaoqi Liu · University Of Kentucky · R01 · FY2021 · CA
HFH-MSU CSRN ACCrual Enrollment and Screening Site
$548,022Christine Marie Neslund-Dudas · Henry Ford Health + Michigan State University Health Sciences · UG1 · FY2025 · CA
Pulsed Focused Ultrasound (pFUS) exposures and devices for tissue permeabilization without contrast agents
$547,894Tatiana Khokhlova · University Of Washington · R01 · FY2020 · EB
The Maryland Regional Community Network Program To Elim*
$547,855Claudia Rose Baquet · University Of Maryland Baltimore · U01 · FY2007 · CA
UCSF PROSTATE CANCER SPORE
$547,618Peter R Carroll · University Of California, San Francisco · P50 · FY2008 · CA
Role and targeting of PRMT5 in prostate cancer
$547,569Chang-Deng Hu · Purdue University · R01 · FY2017 · CA
REGULATING CANCER-ASSOCIATED FIBROBLAST BIOLOGY IN PROSTATE CANCER
$547,530University Of Arizona · · FY2015 · Department of Defense
HYALURONIC ACID AS A TARGET FOR INTERVENTION IN PROSTATE CANCER METASTASES.
$547,500The University Of Texas Health Science Center At San Antonio · · FY2008 · Department of the Army
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
$547,494Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Biospeciman Core
$547,428Robert Vessella · University Of Washington · P01 · FY2010 · CA
Pax2 Interacting Proteins in Development and Disease
$547,404Gregory R Dressler · University Of Michigan At Ann Arbor · R01 · FY2015 · DK
CBFBETA: A NOVEL THERAEUTIC TARGET FOR PROSTATE CANCER
$547,393Louisiana State University · · FY2009 · Department of Defense